Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Vincent, Benjamin G  [Clear All Filters]
2024
Grover NS, Hucks G, Riches ML, Ivanova A, Moore DT, Shea TC, Seegars MBeth, Armistead PM, Kasow KA, Beaven AW, et al. Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30 lymphoma: a phase 1 study. Lancet Haematol. 2024.
2021
Story CMcIlwaine, Wang T, Bhatt VRaj, Battiwalla M, Badawy SM, Kamoun M, Gragert L, Brown V, Baxter-Lowe LAnn, Marsh SGe, et al. Genetics of HLA peptide presentation, and impact on outcomes in HLA-matched allo-HCT. Transplant Cell Ther. 2021.
Tschernia NP, Kumar V, Moore DT, Vincent BG, Coombs CC, Van Deventer H, Foster MC, DeZern AE, Luznik L, Riches ML, et al. Safety and efficacy of pembrolizumab prior to allogeneic stem cell transplant in Acute Myeloid Leukemia. Transplant Cell Ther. 2021.
2019
Raval JS, Park YA, Perjar I, Mazepa MA, Vincent BG, Ma AD, Rollins-Raval MA. Heparin-induced thrombocytopenia associated with collection of hematopoietic progenitor cells by apheresis. J Clin Apher. 2019.
Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Yang T-HOu, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, et al. The Immune Landscape of Cancer. Immunity. 2019;51(2):411-412.
2018
Davis JMichaud, Ivanova A, Chung Y, J Shaw R, Rao K, Sharf JPtachcinsk, Serody J, Armistead P, Wood WA, Coghill J, et al. Evaluation of a Test Dose Strategy for Pharmacokinetically-guided Busulfan Dosing for Hematopoietic Stem Cell Transplant. Biol Blood Marrow Transplant. 2018.